SYRA · Syra Health Corp · Insider Trading

20% of the restricted stock units vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.

20% of the options vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.

20% of the Performance Stock Units vest each year after date of grant subject to the achievement of certain company financial metrics.

20% of the Performance Stock Units vest one year after date of grant and the remainder vest upon the achievement of certain company financial metrics.

20% of the options vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.

20% of the RSUs vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan.1/3 of the options vest on December 31, 2025 and the remainder vest in equal amounts on each of December 31, 2026 and 2027.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan. 1/3 of the options vest on December 31, 2025 and the remainder vest in equal amounts on each of December 31, 2026 and 2027.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan. 1/3 of the options vest on December 31, 2025 and the remainder vest in equal amounts on each of December 31, 2026 and 2027.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.

Held beneficially by the spouse of the Reporting Person.

Held beneficially by the spouse of the Reporting Person.

Held beneficially by the spouse of the Reporting Person.

Held beneficially by the spouse of the Reporting Person.

Held beneficially by the spouse of the Reporting Person.

Held beneficially by the spouse of the Reporting Person.

Held beneficially by the spouse of the Reporting Person.

Held beneficially by the spouse of the Reporting Person.

This purchase price reflects a weighted average of multiple prices ranging from $1.05 to approximately $1.21. Full information regarding the number of shares purchased at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

Held beneficially by the spouse of the Reporting Person.

This sales price reflects a weighted average of multiple prices ranging from $1.12 to $1.15. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

Held beneficially by the spouse of the Reporting Person.

This purchase price reflects a weighted average of multiple prices ranging from $1.20 to $1.28. Full information regarding the number of shares purchased at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.

Held beneficially by the spouse of the Reporting Person.

The options shall vest in four equal annual installments with the first installment vesting on the date of grant.

Held beneficially by the spouse of the Reporting Person.

The options shall vest in four equal annual installments with the first installment vesting on the date of grant.

The options shall vest in four equal annual installments with the first installment vesting on the date of grant.